Where does Gen-Probe Prodesse, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gen-Probe Prodesse, Inc. ranks #35,463 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gen-Probe Prodesse, Inc. hold?

Gen-Probe Prodesse, Inc. holds 7 US utility patents granted between 2020 and 2025, spanning 3 technology areas.

What is Gen-Probe Prodesse, Inc.'s Innovation Score?

Gen-Probe Prodesse, Inc. has an Innovation Score of 29.3 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Gen-Probe Prodesse, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Gen-Probe Prodesse, Inc..

What does claim depth mean for Gen-Probe Prodesse, Inc.'s patents?

Gen-Probe Prodesse, Inc.'s patents average 21.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gen-Probe Prodesse, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Gen-Probe Prodesse, Inc.

Q: What technology areas does Gen-Probe Prodesse, Inc. focus on?

Gen-Probe Prodesse, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 7 patents, ranking #618 of 2,502 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gen-probe ranks #35,463 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#35,463
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.3/100): 21.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R35463 · US Corporation #35,463 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #35,463/49,997
PHOTO-FINISH Geenee
CPC-NARROW C12Q · 3 areas
INNOV-THIN 29.3/100
CLAIMS-DENSE 21.1 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Geenee GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gen-probe’s 29.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (25%) Velocity 3.3 pts (11%) Breadth 6.1 pts (21%) Claim depth 12.7 pts (43%)

Qualcomm Incorporated · highest

85
Gen-Probe Prodesse · this assignee

29
3D Lighting… · lowest

7

What this shows Gen-probe's Innovation Score is 29.3/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gen-probe?

Each dot is one of Gen-probe’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gen-probe’s own 21.1 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Gen-probe vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gen-probe's grants concentrate

Gen-Probe Prodesse, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2023. By volume, Gen-probe sits between Geenee GmbH and General Compression, Inc..

Gen-probe's three-year grant acceleration

Gen-Probe Prodesse, Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Geenee

7
Geissler Companies

7
Gelion Pty

7
Gemalto

7
Geneon

7
Genvivo

7
Geneohm Sciences…

7
General Compressi…

7
Gen-probe Prodesse ◀

7

What this shows Gen-Probe holds 7 patents at rank #35,522, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gen-Probe

By rank, the assignees closest to #35,522 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Gen-Probe's primary technology class.

Gen-probe's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Gen-Probe Prodesse, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	28.6%
2021	2	28.6%
2023	1	14.3%
2024	1	14.3%
2025partial year	1	14.3%

Which technologies does Gen-Probe Prodesse, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gen-Probe Prodesse, Inc.'s patent record in context - here's where to go next.

Gen-Probe Prodesse, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #35,463 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gen-Probe Prodesse, Inc. against Geenee GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.